Previous close | 159.05 |
Open | 157.92 |
Bid | 155.11 x 100 |
Ask | 156.42 x 100 |
Day's range | 153.74 - 157.71 |
52-week range | 82.09 - 189.97 |
Volume | |
Avg. volume | 397,530 |
Market cap | 4.439B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 399.18 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The heavy selling pressure might have exhausted for Krystal Biotech (KRYS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Krystal Biotech (KRYS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...